AbbVie
NYSE:ABBV
$ 230,11
$-2,24 (-0,96%)
230,11 $
$-2,24 (-0,96%)
End-of-day quote: 03/06/2026

Quick Analysis

$10,00
Earnings Per Share
$34,60
Revenue Per Share
71,64%
Gross Margin %
$406,87 B
Market Cap
$60,32 B
Long-Term Debt
Earnings Per Share
$10,00
Revenue Per Share
$34,60
Gross Margin %
71,64%
Market Cap
$406,87 B
Long-Term Debt
$60,32 B

Financials

Year Year 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012
EPS Earnings Per Share $10,00 $10,12 $11,11 $13,77 $12,70 $10,56 $8,94 $7,91 $5,60 $4,82 $4,29 $3,32 $3,14 $3,35
Earnings Earnings $17,67B $17,87B $19,63B $24,36B $22,46B $18,65B $13,22B $11,67B $8,89B $7,68B $6,91B $5,29B $4,99B $5,28B
RPS Revenue Per Share $34,60 $31,91 $30,75 $32,81 $31,73 $25,93 $22,49 $22,19 $17,77 $16,04 $14,16 $12,52 $11,83 $11,65
Revenue Revenue $61,16B $56,33B $54,32B $58,05B $56,12B $45,78B $33,27B $32,73B $28,22B $25,56B $22,82B $19,96B $18,79B $18,38B
OCF Operating Cash Flow $19,14B $18,81B $22,84B $24,94B $22,78B $17,59B $13,32B $13,43B $9,96B $7,04B $7,54B $3,55B $6,27B $6,35B
FCF Free Cash Flow $18,18B $17,83B $19,54B $24,25B $21,99B $16,79B $12,77B $12,79B $9,43B $6,56B $7,00B $2,94B $5,78B $6,01B
OM Operating Margin 34,69% 32,54% 32,51% 39,54% 35,16% 32,04% 42,83% 36,40% 36,41% 37,53% 38,74% 27,56% 32,02% 36,03%
GM % Gross Margin % 71,64% 70,37% 69,21% 71,53% 69,19% 66,69% 77,64% 76,44% 76,30% 77,40% 81,46% 78,01% 75,62% 75,47%
FCFS Free Cash Flow Per Share $0,00 $10,08 $12,48 $13,69 $12,42 $10,07 $8,62 $8,30 $5,91 $4,05 $4,31 $1,84 $3,63 $3,81
LT Debt Long-Term Debt N/A $60,32B $52,46B $59,49B $64,18B $77,55B $63,03B $35,00B $30,95B $36,44B $29,32B $10,54B $14,29B $14,63B
Sha. Stocks 1.767,38M 1.765,35M 1.766,47M 1.769,4M 1.768,75M 1.765,88M 1.479,16M 1.475,08M 1.587,97M 1.593,92M 1.611,24M 1.593,89M 1.588,52M 1.577,33M
×